Affimed NV
NASDAQ:AFMD

Watchlist Manager
Affimed NV Logo
Affimed NV
NASDAQ:AFMD
Watchlist
Price: 0.1815 USD -34.95% Market Closed
Market Cap: 750k USD

Wall Street
Price Targets

AFMD Price Targets Summary
Affimed NV

There are no price targets for AFMD.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Affimed NV Competitors:
Price Targets
PAR
Paradigm Biopharmaceuticals Ltd
82% Upside
6160
Beigene Ltd
16% Upside
SPRO
Spero Therapeutics Inc
106% Upside
VCEL
Vericel Corp
62% Upside
300122
Chongqing Zhifei Biological Products Co Ltd
38% Upside
2487
Cutia Therapeutics
14% Downside
688331
RemeGen Co Ltd
23% Downside
BIOPOR
Bioporto A/S
193% Upside

Revenue
Forecast

Revenue Estimate
Affimed NV

For the last 8 years the compound annual growth rate for Affimed NV's revenue is 1%. The projected CAGR for the next 4 years is 14%.

1%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Affimed NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Affimed NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-57%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AFMD's stock price target?
Not Available

AFMD doesn't have any price targets made by Wall Street professionals.

What is Affimed NV's Revenue forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Affimed NV's revenue is 1%. The projected CAGR for the next 4 years is 14%.

Back to Top